lutetium has been researched along with Carcinoma, Epidermoid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calejo, MT; Cardoso, AL; Cardoso, AM; Cruz, R; Jurado, AS; Morais, CM; Nyström, B; Pedroso de Lima, MC; Zhu, K | 1 |
| Jia, B; Jin, Z; Li, F; Liu, H; Liu, Z; Ma, T; Shi, J; Sun, X; Wang, F; Zhao, H | 1 |
| An, GI; Kang, JH; Kim, KI; Lee, BC; Lee, HW; Lee, JS; Lee, TS; Lee, YJ; Lim, SM; Moon, BS; Park, YS; Song, IH | 1 |
| Beran, M; Eigner, S; Henke, KE; Lebeda, O; Melichar, F; Vera, DR | 1 |
| Bao, A; Cheng, Z; Cutler, CS; Hoppmann, S; Jiang, H; Liu, H; Miao, Z; Qi, S | 1 |
| Wiwanitkit, V | 1 |
| Leemans, CR; Perk, LR; Stigter-van Walsum, M; Tijink, BM; van Dongen, GA; Visser, GW; Vosjan, MJ | 1 |
7 other study(ies) available for lutetium and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Application of thermoresponsive PNIPAAM-b-PAMPTMA diblock copolymers in siRNA delivery.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Proliferation; Cetuximab; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Lutetium; Mice; Mice, Inbred BALB C; Panitumumab; Radioimmunotherapy; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Xenograft Model Antitumor Assays | 2014 |
177Lu-labeled antibodies for EGFR-targeted SPECT/CT imaging and radioimmunotherapy in a preclinical head and neck carcinoma model.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Proliferation; Cetuximab; ErbB Receptors; Female; Head and Neck Neoplasms; Lutetium; Mice; Mice, Inbred BALB C; Panitumumab; Radioimmunotherapy; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Xenograft Model Antitumor Assays | 2014 |
Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Chelating Agents; Copper Radioisotopes; ErbB Receptors; Esophageal Neoplasms; Humans; In Situ Nick-End Labeling; Lutetium; Positron Emission Tomography Computed Tomography; Radioimmunotherapy; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Whole Body Imaging | 2016 |
Preparation and preclinical evaluation of 177Lu-nimotuzumab targeting epidermal growth factor receptor overexpressing tumors.
Topics: Animals; Antibodies, Monoclonal, Humanized; Carcinoma, Squamous Cell; ErbB Receptors; Humans; Immunoconjugates; Immunologic Factors; Lutetium; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Radiation Dosage; Radioimmunotherapy; Radioisotopes; Tissue Distribution | 2012 |
177Lu-DO3A-HSA-Z EGFR:1907: characterization as a potential radiopharmaceutical for radionuclide therapy of EGFR-expressing head and neck carcinomas.
Topics: Amino Acid Sequence; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Copper; ErbB Receptors; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Mice; Mice, Nude; Models, Molecular; Molecular Sequence Data; Peptides; Positron-Emission Tomography; Radiopharmaceuticals; Serum Albumin; Squamous Cell Carcinoma of Head and Neck; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2012 |
177Lu-nimotuzumab.
Topics: Animals; Antibodies, Monoclonal, Humanized; Carcinoma, Squamous Cell; Humans; Lutetium; Neoplasms, Experimental; Radioisotopes | 2012 |
(89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Delivery Systems; Female; Humans; Lutetium; Metabolic Clearance Rate; Mice; Mice, Nude; Organ Specificity; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Yttrium Radioisotopes; Zirconium | 2005 |